NEW YORK, Oct. 12 – Shares in Cepheid skyrocketed nearly 50 percent during mid-day trading on Friday after reports surfaced that an employee of NBC in New York was diagnosed with anthrax.

As of 2:00 p.m. EST, shares in the company, which makes and sells technology that performs genetic testing, were trading up more than 48 percent at $8.10 on the Nasdaq but eased a bit one hour later.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.